From Laboratory to Patient: The Evolving Path to Become a Medicine
Gene editing and other laboratory developments promise to revolutionize treatment of many diseases that currently have no cure. The process to become a medicine is long and complex and requires many years. Regulation of medicines (permission to market a product and monitoring of its performance) is...
Main Author: | Ana Hidalgo-Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2019-12-01
|
Series: | Molecular Frontiers Journal |
Subjects: | |
Online Access: | http://www.worldscientific.com/doi/pdf/10.1142/S2529732519400121 |
Similar Items
-
Authorization of Vaccines in the European Union
by: Ana Hidalgo-Simon, et al.
Published: (2021-06-01) -
Cell and Gene Therapies: European View on Challenges in Translation and How to Address Them
by: Cécile F. Rousseau, et al.
Published: (2018-05-01) -
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
by: Paloma Gastelurrutia, et al.
Published: (2021-02-01) -
Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective
by: Maja Pizevska, et al.
Published: (2022-02-01) -
Brief summary of the regulatory frameworks of regenerative medicine therapies
by: Jinah Yoon, et al.
Published: (2025-01-01)